植物来源诺如病毒样颗粒疫苗的研制与特性分析
本研究利用本氏烟草(Nicotiana benthamiana)瞬时表达系统制备了GI和GII基因群诺如病毒样颗粒(NoVLP),并在兔和小鼠中评估了GII.4 NoVLP的安全性和免疫原性。结果表明NoVLP在兔中耐受良好,小鼠肌内注射三剂铝佐剂疫苗可诱导 robust IgG、IgG分泌细胞、组织血型抗原阻断滴度和IFNγ分泌T细胞,口服给药可诱导粪便IgA。作者认为植物制备的NoVLP疫苗安全且有免疫原性,未来临床开发可考虑口服与肌内联合的多模式接种。
要点
- 在本氏烟草中成功表达了15种GI和GII NoVLP,经冷冻透射电镜证实其结构与诺如病毒颗粒相似。
- GII.4 NoVLP在兔中耐受良好,未观察到局部或全身毒性体征。
- 小鼠肌内注射三剂铝佐剂GII.4 NoVLP可诱导IgG、IgG分泌细胞、组织血型抗原阻断滴度和IFNγ分泌T细胞;口服给药可诱导粪便IgA。
核心结论
- 植物制备的NoVLP疫苗在小鼠和兔中安全且有免疫原性。
- 作者认为,未来临床开发可考虑采用口服与肌内联合的多模式接种,以最大化全身和黏膜免疫应答。
研究设计与样本
- 利用基于根癌农杆菌(Agrobacterium tumefaciens)的瞬时表达系统在本氏烟草中生产由GI和GII基因群表面病毒蛋白1(VP1)组成的诺如病毒样颗粒(NoVLP)。
- 将浸润植株的叶片收获后提取纯化NoVLP。
- 随后在兔和小鼠中检验GII.4 NoVLP(当前引起大多数人类疾病的基因型)的安全性和免疫原性。
主要发现
- 15种GI和GII NoVLP在本氏烟草中成功表达,经冷冻透射电镜确定其结构与诺如病毒颗粒相似。
- NoVLP耐受良好,在兔中未出现局部或全身毒性体征。
- 小鼠肌内注射三剂氢氧化铝佐剂GII.4 NoVLP可诱导高水平IgG滴度、IgG分泌细胞、组织血型抗原阻断滴度和IFNγ分泌T细胞。
- 除循环抗体外,小鼠口服NoVLP可诱导粪便中显著IgA水平,提示黏膜应答。
临床怎么用
- 作者认为,未来临床开发可考虑采用口服与肌内联合的多模式接种,以最大化全身和黏膜免疫应答。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Norovirus (NoV) is the most common cause of diarrheal episodes globally. Issues with in vitro cultivation systems, genetic variation, and animal models have hindered vaccine development. Plant-derived virus-like particles (VLPs) may address some of these concerns because they are highly immunogenic, can be administered by different routes, and can be rapidly produced to accommodate emerging viral strains. METHODS: NoV VLPs (NoVLP) composed of the surface viral protein (VP) 1 of the GI and GII genogroups were produced in Nicotiana benthamiana using an Agrobacterium tumefaciens-based recombinant transient expression system. Leaves from infiltrated plants were harvested and NoVLPs were extracted and purified. The safety and immunogenicity of the GII.4 NoVLP, the genotype currently causing most human disease, were subsequently examined in rabbits and mice. RESULTS: Fifteen GI and GII NoVLPs were successfully expressed in N. benthamiana and were structurally similar to NoV virions, as determined by cryogenic transmission electron microscopy. The NoVLP was well-tolerated, with no local or systemic signs of toxicity in rabbits. Three intramuscular doses of the GII.4 NoVLP adjuvanted with aluminum hydroxide induced robust IgG titers, IgG-secreting cells, histo-blood group antigen blocking titers, and IFNγ-secreting T cells in mice. In addition to circulating antibodies, oral administration of the NoVLP in mice induced significant IgA levels in feces, indicative of a mucosal response. CONCLUSIONS: The plant-made NoVLP vaccine was safe and immunogenic in mice and rabbits. Multi-modal vaccination, combining oral and intramuscular administration could be considered for future clinical development to maximize systemic and mucosal immune responses.
引用
- Shapiro JR, Andreani G, Dubé C, et al. Development and characterization of a plant-derived norovirus-like particle vaccine. Vaccine. 2023. PMID: 37625992. doi:10.1016/j.vaccine.2023.08.036
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。